BridgeBio Oncology Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Dec 2025Filed 05/03/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Dec 2024Filed 05/03/2026 | Sep 2024Filed 12/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $3.6 | $3.9 | $4.4 | $3.4 | $0 | $0 | $2.1 | $0 | |
| −$56 | −$42 | −$39 | −$45 | −$28 | −$22 | −$20 | −$17 | |
| −$705.20 | −$526.11 | −$0.49 | −$1.03 | −$566.46 | −$54.23 | −$1075.56 | −$1562.18 | |
| 80 | — | 80 | 43 | 50 | 0.4 | 0 | 0 |
Trend